WCN26-8305 PREDICTORS OF CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME PROGRESSION AND GAPS IN CARE AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE

Read full text Summarise with VIRAT
Authors: Melanie R. Weltman, Zhuoheng Han, Linda-Marie Ustaris Lavenburg, Jonathan Guerrero Yabes, Manisha Jhamb
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Cardiovascular-kidney-metabolic syndrome (CKM) is the bidirectional relationship between cardiovascular disease (CVD), chronic kidney disease (CKD), diabetes, and obesity. CKM stage 2 includes metabolic risk factors of CVD, CKM stage 3 includes subclinical CVD, and CKM stage 4 includes clinical CVD. These CKM stages encompass heterogeneous patient phenotypes with varying presence and severity of CKD who may have different risks of cardiovascular and kidney adverse events. Our goal is to describe the distribution of CKM stages among patients with CKD, identify predictors of progression to CKM stage 4, and evaluate gaps in evidence-based care before and after transitioning to CKM stage 4.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Diabetes Cardiovascular Risks and Lipoproteins Dialysis and Renal Disease Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104921–104921
Publication date
25 March 2026
Language
EN